Our results also contradict the previously established notion that METCAM/MUC18 serves as a tumor promoter in both prostate cancer cells [22] and breast cancer cells [23, 24], and as a metastasis promoter in human melanoma cells [25], prostate cancer [26], and breast cancer [27]. Here, MCAM is linked to breast carcinoma.